An artificial intelligence summit where world healthcare leaders come together.
The 2022 AI Summit attracted more than 95 participants who journeyed together through a wide range of topics, built bridges to different ideas and concepts, and came away with action items and plans to move AI in healthcare forward.
If you are looking for solutions to launch and advance AI capabilities, join us next year.
Mark your calendar now for the 2023 AI Summit November 14 – 16, 2023
Don’t want to wait to get involved?
2022 Featured Speakers
Senior Director, Global Digital Health Strategy & Regulatory, Google
Co-founder and CSO, Aizon
Regulatory Head of Global Software Standards,
Jesse M. Ehrenfeld
President-Elect, American Medical Association
Associate Director Regulatory Policy, BD
Chief Compliance Officer – GxP Operations, Sierra Labs
Regulatory Affairs Manager, BD
Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding
Join us at the 2023 AI Summit
Join us for a behind-the-scenes look into how Artificial Intelligence (AI) is being used in pharma, biopharma, and medical devices! The 2022 summit was held in person in Columbus, Ohio.
Prior Featured Topics
QMS Case Study – A Real-World Experience Aligning AI/ML Activities with a Compliant QMS
Current AI Global Regulatory and Standards Landscape
AI-Enabled Device to Market Through a Pandemic
Lessons Learned and Pitfalls When Deploying AI in GxP Environments
How AI Can Be Used in
3D Printing & Smart Manufacturing
Learn What the Industry-Led AI Working Teams Have Been Up To
Who should attend the AI Summit?
Quality, regulatory, operations, and R&D professionals in the healthcare space
Healthcare professionals who are using or building AI solutions
Clinical trial managers
Biopharma and biotech professionals
Consultants and service providers to the life science industries
Data scientists and AI experts
This meeting is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award FAIN R13FD007707 totaling $50,000 funded by FDA/HHS and $76,000 amount and funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.